ANDREW BROWN, M.D.
Ophthalmology Physician in TEANECK, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: ANDREW BROWN, M.D. reported a CMS MIPS final score of 75.8046 out of 100, below the 83.1 national average, and filed 2,938 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
ANDREW BROWN, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
ANDREW BROWN, M.D. at a glance
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New Jersey
How Ophthalmology Physician compares to other specialties among New Jersey providers
Ophthalmology Physician share within New Jersey
Ophthalmology Physician is one of the more visible NUCC categories in New Jersey
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
ANDREW BROWN, M.D.'s 2023 MIPS final score plotted against the Ophthalmology Physician national average
- MIPS Final Score
- 75.8046/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Ophthalmology Physician) — 75.8046/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Ophthalmology Physician US NPIs
75.8046/100 MIPS final score — 7.3 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Ophthalmology Physician. Quality dim: 68.6551. Cost dim: 50.6935.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
ANDREW BROWN, M.D. is a Ophthalmology Physician provider practicing in TEANECK, New Jersey, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1174595987. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
ANDREW BROWN, M.D. appears in the CMS NPPES registry as a Ophthalmology Physician provider holding M.D. credentials at 751 TEANECK RD, TEANECK, NJ, 07666, with a listed phone of (201) 833-0006. NPI 1174595987 was issued on 02/06/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BROWN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 2,938 prescription claims written by this provider, covering 681 Medicare beneficiaries and totaling roughly $708K in drug spend, split 44% brand-name and 56% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75.8046/100 for the 2023 performance year (Quality 68.6551, Cost 50.6935), compared with the national average of 83.1.
Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1174595987 |
|---|---|
| Specialty | Ophthalmology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 02/06/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm ANDREW BROWN, M.D.'s current license status, disciplinary history, and board certifications with the New Jersey State Board of Medical Examiners in New Jersey before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where ANDREW BROWN, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ANDREW BROWN, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$1.4K
Largest payer
Tarsus Pharmaceuticals, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
44% brand-name claims vs 56% generic, on 2,938 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 6,061
- Total Day Supply
- 175,153
- Brand vs Generic
- 44% brand / 56% generic
- Brand Drug Cost
- $632K
- Generic Drug Cost
- $76K
Patient Demographics
- Average Patient Age
- 77.7 years
- Avg HCC Risk Score
- 1.16
- Gender Split
- 66% female / 34% male
- Age Distribution
- <65: 12, 65-74: 241, 75-84: 289, 85+: 139
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Latanoprost | 1,130 |
| Lumigan Bimatoprost | 296 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 201 |
| Timolol Maleate | 198 |
| Restasis Cyclosporine | 114 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 111 |
| Combigan Brimonidine Tartrate/Timolol | 90 |
| Dorzolamide Hcl | 85 |
| Prednisolone Acetate | 73 |
| Alphagan P Brimonidine Tartrate | 59 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmology Physician Overview
How ANDREW BROWN, M.D. fits within the Ophthalmology Physician landscape nationally.
ANDREW BROWN, M.D.'s 2,938 claims are above the specialty average of 1,420.
Nearby Ophthalmology Physician Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as BROWN.
Compare Ophthalmology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New Jersey
Frequently Asked Questions
What is ANDREW BROWN, M.D.'s specialty? ▼
How much does ANDREW BROWN, M.D. prescribe under Medicare Part D? ▼
What is ANDREW BROWN, M.D.'s Medicare quality score? ▼
Where is ANDREW BROWN, M.D. located? ▼
What is ANDREW BROWN, M.D.'s NPI number? ▼
Does ANDREW BROWN, M.D. prescribe more brand-name or generic drugs? ▼
How many Ophthalmology Physician providers are there in the US? ▼
What drugs does ANDREW BROWN, M.D. prescribe most often? ▼
Does ANDREW BROWN, M.D. accept Medicare? ▼
How can I verify ANDREW BROWN, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology